Minimal/Measurable Residual Disease Monitoring in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives

Minimal/Measurable Residual Disease Monitoring in <i>NPM1</i>-Mutated Acute Myeloid Leukemia: A Clinical Viewpoint and Perspectives

Acute myeloid leukemia (AML) with <i>NPM1</i> gene mutations is currently recognized as a distinct entity, due to its unique biological and clinical features. We summarize here the results of published studies investigating the clinical application of minimal/measurable residual disease...

Full description

Bibliographic Details
Main Authors:	Fabio Forghieri, Patrizia Comoli, Roberto Marasca, Leonardo Potenza, Mario Luppi
Format:	Article
Language:	English
Published:	MDPI AG 2018-11-01
Series:	International Journal of Molecular Sciences
Subjects:	<i>NPM1</i>-mutated acute myeloid leukemia molecular minimal/measurable residual disease monitoring prognostic thresholds and timepoints intensive chemotherapy allogeneic hematopoietic stem cell transplantation clinical outcome
Online Access:	https://www.mdpi.com/1422-0067/19/11/3492

Similar Items

How to Improve Prognostication in Acute Myeloid Leukemia with <i>CBFB-MYH11</i> Fusion Transcript: Focus on the Role of Molecular Measurable Residual Disease (MRD) Monitoring
by: Annalisa Talami, et al.
Published: (2021-08-01)

Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with <i>NPM1</i> Positive Acute Myeloid Leukemia
by: Federico Lussana, et al.
Published: (2019-09-01)

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia
by: Fabio Forghieri, et al.
Published: (2021-08-01)

<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
by: Fabio Forghieri, et al.
Published: (2020-11-01)

<i>TET2/IDH1/2/WT1</i> and <i>NPM1</i> Mutations Influence the <i>RUNX1</i> Expression Correlations in Acute Myeloid Leukemia
by: Sergiu Pasca, et al.
Published: (2020-11-01)

A Curious Novel Combination of <i>Nucleophosmin</i> (<i>NPM1</i>) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of <i>NPM1</i> in Acute Myeloid Leukemia (AML)
by: Alessandra Venanzi, et al.
Published: (2021-09-01)

NPM1A in plasma is a potential prognostic biomarker in acute myeloid leukemia
by: Sun Chengming, et al.
Published: (2018-08-01)

Recurrent SETD2 mutation in NPM1-mutated acute myeloid leukemia
by: Jiewen Sun, et al.
Published: (2020-11-01)

Evaluation of Minimal Residual Disease in Acute Myeloid Leukemia with NPM1 Marker
by: Nasrin Alizad Ghandforoush, et al.
Published: (2016-06-01)

Fludarabine, High-Dose Cytarabine and Idarubicin-Based Induction May Overcome the Negative Prognostic Impact of <i>FLT3</i>-ITD in <i>NPM1</i> Mutated AML, Irrespectively of <i>FLT3</i>-ITD Allelic Burden
by: Paola Minetto, et al.
Published: (2021-12-01)

Minimal Residual Disease as a Predictive Factor for Relapse after Allogeneic Hematopoietic Stem Cell Transplant in Adult Patients with Acute Myeloid Leukemia in First and Second Complete Remission
by: Rada M. Grubovikj, et al.
Published: (2012-06-01)

Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AML
by: Anna Wojtuszkiewicz, et al.
Published: (2021-08-01)

Development of program therapy for patients with acute myeloid leukemia under the age of 60 years, based on the principles of differentiated effects
by: Elena N. Parovichnikova, et al.
Published: (2021-07-01)

Outcomes of adult patients with acute myeloid leukemia and unsuccessful cytogenetic analysis undergoing allogeneic hematopoietic stem cell transplantation
by: Ram Vasudevan Nampoothiri, et al.
Published: (2021-06-01)

The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
by: Heiblig Maël, et al.
Published: (2021-04-01)

NPM1 and FLT3-(ITD) Gene mutations and laboratory findings in patients with acute myeloid leukemia in Northwest of Iran
by: Sanaat Z, et al.
Published: (2014-10-01)

CEBPE expression is an independent prognostic factor for acute myeloid leukemia
by: Kening Li, et al.
Published: (2019-06-01)

OUTCOME OF ALLOGENEIC STEM CELL TRANSPLANTATION WITH ACTIVE DISEASE IN ACUTE MYELOID LEUKEMIA
by: Mehmet Bakirtas, et al.
Published: (2020-06-01)

The correlation of next-generation sequencing-based genotypic profiles with clinicopathologic characteristics in NPM1-mutated acute myeloid leukemia
by: Biao Wang, et al.
Published: (2021-07-01)

NPM1 and FLT3-ITD/TKD Gene Mutations in Acute Myeloid Leukemia
by: Shano Naseem, et al.
Published: (2021-01-01)

Nucleophosmin 1 expression in acute myeloid leukemia
by: Mohammad Davoudi, et al.
Published: (2015-09-01)

Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case study
by: Tripon Florin, et al.
Published: (2019-07-01)

Rare myeloid sarcoma/acute myeloid leukemia with adrenal mass after allogeneic mobilization peripheral blood stem cell transplantation
by: Ya-Fei Wang, et al.
Published: (2013-12-01)

CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells
by: Vincenzo Maria Perriello, et al.
Published: (2021-01-01)

Genetic Stratification in Myeloid Diseases: From Risk Assessment to Clinical Decision Support Tool
by: Yishai Ofran
Published: (2014-10-01)

Maintenance therapy in acute myeloid leukemia after allogeneic hematopoietic stem cell transplantation
by: Li Xuan, et al.
Published: (2021-01-01)

Outcome of Allogeneic Hematopoietic Stem Cell Transplantation in Acute Myeloid Leukemias with Hyperdiploid Karyotype
by: TL Gindina, et al.
Published: (2016-10-01)

Risk factors affect accurate prognosis in ASXL1-mutated acute myeloid leukemia
by: Yi Fan, et al.
Published: (2021-10-01)

Significance of NPM1 Gene Mutations in AML
by: Andrew Hindley, et al.
Published: (2021-09-01)

Second allogeneic hematopoietic stem cell transplantation in treatment of relapsed acute myeloid leukemia: clinical report of 5 cases
by: LIN Shijia, et al.
Published: (2019-12-01)

Modelling the Effects of MCM7 Variants, Somatic Mutations, and Clinical Features on Acute Myeloid Leukemia Susceptibility and Prognosis
by: Florin Tripon, et al.
Published: (2020-01-01)

FLT3 and NPM1 gene mutations in patients with acute myeloid leukemias and the impact of FLT3-ITD mutations on the survival of patients with a normal karyotype
by: Irina Stepanovna Martynkevich, et al.
Published: (2010-12-01)

Conditioning Intensity, Pre-Transplant Flow Cytometric Measurable Residual Disease, and Outcome in Adults with Acute Myeloid Leukemia Undergoing Allogeneic Hematopoietic Cell Transplantation
by: Linde M. Morsink, et al.
Published: (2020-08-01)

Prognostic Value of MicroRNA-20b in Acute Myeloid Leukemia
by: Zhiheng Cheng, et al.
Published: (2021-02-01)

Fungemia and necrotic lymph node infection with Sporopachydermia cereana in a patient with acute myeloid leukemia
by: Craig Kingston, et al.
Published: (2017-08-01)

Reduced Intensity versus Full Myeloablative Conditioning in Allogeneic Stem Cell Transplantation for Acute Myeloid Leukemia
by: Kamran Alimoghaddam, et al.
Published: (2011-09-01)

The Role of the <i>HOXA</i> Gene Family in Acute Myeloid Leukemia
by: Si-Liang Chen, et al.
Published: (2019-08-01)

Upregulation of Glutamic-Oxaloacetic Transaminase 1 Predicts Poor Prognosis in Acute Myeloid Leukemia
by: Zhiheng Cheng, et al.
Published: (2020-03-01)

Allogeneic stem cell transplantation in acute myeloid leukemia
by: Natasha Ali, et al.
Published: (2012-11-01)

Chronic myelomonocytic leukemia “myelodysplastic type’’ in transformation to acute myeloid leukemia – diagnostic and therapeutic options: case report and literature review / Leucemie mielomonocitară cronică forma mielodisplazică în transformare spre leucemie acută mieloidă – diagnostic și opțiuni terapeutice: prezentare de caz și revizuirea literaturii
by: Cîrstea Mihaela, et al.
Published: (2016-09-01)

Cannot write session to /tmp/vufind_sessions/sess_fts84atn18g59ehqsgqfa7rddg